“Our results suggest that oscillometry . . . may serve as valuable, noninvasive biomarkers for early detection, risk stratification, and longitudinal monitoring of IPF,” the authors concluded.

A new risk stratification model for idiopathic pulmonary fibrosis could shift treatment from passive monitoring to active, goal-oriented care.

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

A rare physiological case study shows how aerobic capacity, muscle adaptation, and oxygen use can remain remarkably intact well into the eighties.

As artificial intelligence reshapes geopolitics, economies and democratic processes, one reality is becoming impossible to ignore: AI is no longer just a technology conversation. It is a power ...

The AI Impact Summit in New Delhi brought together nearly 90 nations, but its voluntary framework exposed the limits of ...

The C919 is a homegrown helicopter in China that has travelled many miles since it first appeared in the commercial airspace ...

After weeks of skepticism and even industry figures calling its solid-state battery claims a ...

As state legislatures convene across the country, education policymakers face an unfamiliar scenario: Federal oversight has ...

Anduril, in announcing the first flight of its YFQ-44A in October 2025, said it had started weapons integration tests. Over 2026, the company expects to execute the first live shot of a weapon, ...

High-throughput neutralisation tests could lead to a better understanding of the evolution of human influenza.